Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.

Neuropsychobiology - 1 Jan 2006

Szczepankiewicz Aleksandra, Skibinska Maria, Hauser Joanna, Slopien Agnieszka, Leszczynska-Rodziewicz Anna, Kapelski Paweł, Dmitrzak-Weglarz Monika, Czerski Piotr M, Rybakowski Janusz K

Abstract excerpt

Glycogen synthase kinase-3beta (GSK-3beta) has been implicated in the pathogenesis of major psychoses. In this paper, the T-50C polymorphism of the GSK-3beta gene has been studied in patients with schizophrenia (n=432), patients with bipolar disorder (n=416) and in a healthy control group (n=408)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Chi-Square Distribution
Share to Glycogen Synthase Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen Synthase Kinase 3 beta

Share to Poland

Share to Reference Values

Share to Schizophrenia

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 16397405
DOI: 10.1159/000090704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16397405-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.PMID 16397405Read ↗

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.Semantic proximity Read ↗

Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.Semantic proximity Read ↗

Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder.Semantic proximity Read ↗

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.Semantic proximity Read ↗

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.Semantic proximity Read ↗

Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.Semantic proximity Read ↗

The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.Semantic proximity Read ↗

No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.Semantic proximity Read ↗

The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.Semantic proximity Read ↗

Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.Semantic proximity Read ↗

Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.Semantic proximity Read ↗

[Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.